A Science and Technology Blog
The study has been published in the journal Mayo Clinic Proceedings. “Our study shows that COVID-19 vaccines have a great benefit in reducing infection and severity of disease. Vaccination helps…
The study evaluated the neutralisation potential in people vaccinated with Covaxin and found that there was a 3- and 2.7-fold reduction in neutralisation titers against the beta (B.1.351) and delta…
The seropositivity rates and the median antibody titre against spike protein was “significantly higher” in those vaccinated with Covishield compared with Covaxin, according to a preprint posted in medRxiv. Preprints…
With the alpha (B.1.1.7) and delta (B.1.617.2) variants widely present across the country, and the possibility of new variants with higher transmissive ability getting imported or emerging in India cannot…
India approved Covishield with an interval of four-six weeks between two doses despite the MHRA approving AstraZeneca with a 4-12 weeks gap and JCVI approving a 12-week prime-boost interval. What…
According to the PIB release, the myth was that the Centre wasn’t taking any step to vaccinate children. Clarifying this, Dr. Paul said: “As of now, no country in the…
A concerned Health Ministry has now asked all States to classify mucormycosis, a fungal infection, as a notifiable disease under the Epidemic Diseases Act 1897; a few States have complied.…
On August 7, a week before Mr. Modi’s announcement, the Pune-based Serum Institute signed an agreement with GAVI and Gates Foundation to manufacture and deliver up to 100 million doses…
